Feb 09, 2021
Q4 Report 2020 - invitation to conference call and audiocast
Jan 12, 2021
IRRAS Announces Collaboration with Karolinska University Hospital
Dec 10, 2020
IRRAS Announces Expansion of IRRAflow Launch to Latin America
Nov 17, 2020
IRRAS Awarded Breakthrough Technology Purchasing Agreement with Premier for Hummingbird ICP Monitoring Products
Nov 10, 2020
IRRAS AB publishes Interim Report for the period January to September 2020
Oct 22, 2020
IRRAS Announces Key IRRAflow Commercial Milestones in Germany
Aug 25, 2020
IRRAS Granted Sixth Patent for Hummingbird ICP Monitoring Product Line from United States Patent and Trademark Office (USPTO)
Aug 05, 2020
IRRAS to Present Virtually at Upcoming Investor Conferences
Jul 22, 2020
IRRAS Announces Extension of CE Mark for IRRAflow System Until May 2024
Jun 30, 2020
COVID-19 Delays Short Term Revenue, While the Commercial Launch of IRRAflow and Hummingbird Progresses
Jun 15, 2020
IRRAS Announces Promotion of Will Martin to President and Chief Commercial Officer
May 19, 2020
IRRAS has Been Approved for Listing on Nasdaq Stockholm and Publishes Prospectus
May 11, 2020
IRRAS: Q1 Report 2020 - Invitation to Conference Call and Audiocast
Mar 25, 2020
University of Helsinki, a Global Neurosurgery Leader and IRRAS Will Collaborate to Advance Uses of IRRAflow
Feb 14, 2020
IRRAS AB Publishes Interim Report for the Period January to December 2019
Jan 30, 2020
IRRAS: Q4 Report 2019 - Invitation to Conference Call and Audiocast
Jan 07, 2020
IRRAS Provides US Launch Update, Product Portfolio Progress and Objectives for 2020
Dec 19, 2019
IRRAS Receives Renewed CE Mark for the IRRAflow Catheter
Dec 16, 2019
IRRAS Announces US Launch of Hummingbird Products for Neurocritical Care
Dec 09, 2019
IRRAflow® Wins CONNECT's "2019 Most Innovative New Product" Award